Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Retrophin Inc (RTRX)

Retrophin Inc (RTRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,238,011
  • Shares Outstanding, K 51,052
  • Annual Sales, $ 175,340 K
  • Annual Income, $ -146,430 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 0.71
  • Price/Sales 7.09
  • Price/Cash Flow N/A
  • Price/Book 4.10
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.70
  • Most Recent Earnings $-0.26 on 02/24/20
  • Next Earnings Date 11/05/20
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/20
See More
  • Average Estimate -0.44
  • Number of Estimates 4
  • High Estimate -0.35
  • Low Estimate -0.59
  • Prior Year -0.70
  • Growth Rate Est. (year over year) +37.14%

Price Performance

See More
Period Period Low Period High Performance
1-Month
19.52 +24.23%
on 11/02/20
24.96 -2.84%
on 11/11/20
+2.36 (+10.78%)
since 10/16/20
3-Month
17.22 +40.82%
on 09/24/20
24.96 -2.84%
on 11/11/20
+5.82 (+31.58%)
since 08/18/20
52-Week
8.98 +170.04%
on 03/18/20
24.96 -2.84%
on 11/11/20
+11.23 (+86.32%)
since 11/18/19

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

Retrophin is a pharmaceutical company focused on the development, acquisition and commercialization of drugs for the treatment of serious, catastrophic or rare diseases for which there are currently no viable options for patients. The Company's approved products include Chenodal', Cholbam, and Thiola',...

See More

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 25.04
1st Resistance Point 24.65
Last Price 24.25
1st Support Level 23.95
2nd Support Level 23.64
3rd Support Level N/A

See More

52-Week High 24.96
Last Price 24.25
Fibonacci 61.8% 18.86
Fibonacci 50% 16.97
Fibonacci 38.2% 15.08
52-Week Low 8.98

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar